PVT1 also upregulated miR-190a-5p and miR-488-3p, resulting in inhibited expression of myocyte enhancer factor 2C (MEF2C), an oncogenic factor in glioma (119). The gene discussed is MEF2C; the disease is central nervous system cancer.